Measurable residual disease (MRD) can predict disease progression in patients who have acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and chronic myeloid leukemia (CML).

New Delhi [India], June 16: To achieve a consensus on a suitable panel and analysis strategy to report Acute Myeloid Leukemia - Measurable Residual Disease (AML-MRD) by flow cytometry, BD Life ...

Ficlatuzumab plus single-agent chemotherapy showed encouraging efficacy and appeared safe among patients with relapsed or refractory acute myeloid leukemia, according to phase 1 study results ...

Among the 109 remission samples, 84 were MRD negative, 24 were MRD positive, and 1 was indeterminate by multiparameter flow cytometry (MFC; FIGURE5). All 24 MRD-positive samples by MFC were also ...

Flow cytometry has long been the standard of care for many blood cancers including acute myeloid leukemia (AML), but to achieve minimal residual disease (MRD) level sensitivity with limited ...

The clinically ideal time point and optimal approach for the assessment of measurable residual disease (MRD) in patients with acute myeloid leukemia (AML) are still inconclusive. We investigated the ...

A recent study described the use of multiparameter flow cytometry (MFC) to detect minimal residual disease (MRD), with an 8-color flow cytometric method with a 10 5 sensitivity, using monoclonal ...

In acute myeloid leukemia (AML), MRD is typically assessed by using flow cytometry and, at some centers, by quantifying NPM1 transcripts — an independent and powerful prognosticator of AML. But ...

Ravandi F, Jorgensen J, Borthakur G, et al. Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia ...

Adaptive Biotechnologies and Collaborators to Present Data Demonstrating High-Throughput Sequencing for Minimal Residual Disease (MRD) is More Sensitive Than Flow Cytometry and Can Be Used as a ...

Measurable (‘minimal’) residual disease (MRD) before or after hematopoietic cell transplantation (HCT) identifies adults with AML at risk of poor outcomes. Here, we studied whether peri ...